<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="23014">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02807181</url>
  </required_header>
  <id_info>
    <org_study_id>STX0115</org_study_id>
    <nct_id>NCT02807181</nct_id>
  </id_info>
  <brief_title>SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma</brief_title>
  <acronym>SIRCCA</acronym>
  <official_title>Prospective, Multicenter, Randomized, Controlled Study Evaluating SIR-Spheres Y-90 Resin Microspheres Preceding Cisplatin-gemcitabine (CIS-GEM) Chemotherapy Versus CIS-GEM Chemotherapy Alone as First-line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sirtex Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sirtex Medical</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will evaluate the benefit of applying Selective Internal Radiation Therapy (SIRT)
      using SIR-Spheres Y-90 resin microspheres prior to receiving systemic chemotherapy treatment
      (cisplatin-gemcitabine, or CIS-GEM) in patients with unresectable intrahepatic
      cholangiocarcinoma. Half of the patients will be randomized to CIS-GEM chemotherapy plus
      SIRT, and half of the patients will be randomized to CIS-GEM alone.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This clinical study is a prospective, multicenter, randomized, controlled study evaluating
      SIR-Spheres Y-90 resin microspheres followed by cisplatin-gemcitabine (CIS-GEM) chemotherapy
      vs. CIS-GEM chemotherapy alone as first-line treatment of patients with unresectable
      intrahepatic cholangiocarcinoma.

      Randomized patients will be followed until death, withdrawal of consent, or until end of
      study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Survival at 18 months</measure>
    <time_frame>18 months following the date of randomization.</time_frame>
    <description>Survival at 18 months is defined as the proportion of patients still alive 18 months from the date of randomization.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Liver-specific progression free survival (PFS)</measure>
    <time_frame>From date of randomization to the first documented date of progression in the liver or date of death from any cause, assessed up to 36 months..</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Progression free survival (PFS) at any site</measure>
    <time_frame>From date of randomization to the date of progression at any site until the first date of documented tumor progression at any site or date of death from any cause, assessed up to 36 months.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Objective response rate by RECIST 1.1 and refined RECIST - liver</measure>
    <time_frame>From the date of first treatment until the date of date of first documented progression in the liver, assessed up to 36 months.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Objective response rate by RECIST 1.1 and refined RECIST - at any site</measure>
    <time_frame>From the date of first treatment until progression at any site, assessed up to 36 months.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Survival</measure>
    <time_frame>From date of randomization until the date of death from any cause, assessed up to 36 months.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver surgical resection and ablation rate</measure>
    <time_frame>18 months following the date of randomization.</time_frame>
    <description>To assess the number of patients in each arm who are downstaged by protocol therapy and can proceed to liver resection or ablation. The specific assessments will be the classification of resection as R0, R1 or R2, the presence of viable tumor or fibrosis, and the nearest resection margin.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Adverse Events (Safety and tolerability)</measure>
    <time_frame>Informed consent until 28 days post last dose of protocol chemotherapy.</time_frame>
    <description>Adverse events as assessed by CTCAE v. 4.0.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Intrahepatic Cholangiocarcinoma</condition>
  <arm_group>
    <arm_group_label>Chemotherapy (Cisplatin-Gemcitabine)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cisplatin 25mg/m2 in 1000ml 0.9% saline given over 1 hour followed by 500 ml 0.9% saline over 30 minutes, followed by Gemcitabine 1000 mg/m2 in 250-500 ml 0.9% saline over 30 minutes by intravenous infusions on days 1, and 8 of a 21-day cycle.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Radiation: SIRT + chemotherapy (Cisplatin-Gemcitabine)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A single treatment of hepatic arterial injection of SIR-Spheres Y-90 resin microspheres (SIRT) followed 14-16 days later by systemic chemotherapy (ABC-02 CIS-GEM protocol) with an intention to treat with 8 cycles of cisplatin + gemcitabine, or until progression, toxicity or patient choice. Treatment may be continued beyond 8 cycles in the absence of significant disease progression, at the treating clinicians' discretion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cisplatin-gemcitabine</intervention_name>
    <description>Systemic chemotherapy</description>
    <arm_group_label>Chemotherapy (Cisplatin-Gemcitabine)</arm_group_label>
    <arm_group_label>Radiation: SIRT + chemotherapy (Cisplatin-Gemcitabine)</arm_group_label>
    <other_name>CIS-GEM</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Radiation: SIRT + chemotherapy (cisplatin-gemcitabine)</intervention_name>
    <description>SIR-Spheres microspheres followed by systemic chemotherapy</description>
    <arm_group_label>Radiation: SIRT + chemotherapy (Cisplatin-Gemcitabine)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Willing, able and mentally competent to provide written informed consent.

          -  Aged 18 years or older.

          -  Histologically or cytologically confirmed unresectable and non-ablatable intrahepatic
             cholangiocarcinoma.

          -  Liver-only or liver predominant intrahepatic cholangiocarcinoma. Patient are
             permitted to have loco-regional lymph node involvement defined as: portal LN &lt;/= to 2
             cm and/or para aortic LN &lt;/= to 1.5 cm in longest diameter, and/or up to 2
             indeterminate lung lesions &lt; 1 cm if these lung lesions are positron emission
             tomography (PET) negative.

          -  Chemotherapy na√Øve. Adjuvant chemotherapy is not permitted.

          -  Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1.

          -  Adequate hematological function defined as:

        Hemoglobin &gt;/= 10g/dL White Blood Cell count (WBC) &gt;/= 3.0 x 10^9/L Absolute neutrophil
        count (ANC) &gt;/= 1.5 x 10^9/L Platelet count &gt;/= 100,000/mm^3 - Adequate liver function
        defined as: Total bilirubin &lt;/= 30 umol/L (1.75 mg/dL) Albumin &gt;/= 30 g/L

        - Adequate renal function defined as: Serum urea and serum creatinine &lt; 1.5 times upper
        limit of normal (ULN) Creatinine clearance &gt;/= 45 ml/min (calculated with Cockcroft-Gault
        Equation)

          -  Life expectancy of at least 3 months without any active treatment

          -  Female patients must either be postmenopausal, sterile (surgically or radiation- or
             chemically-induced), or if sexually active use an acceptable method of contraception
             during the study.

          -  Male patients must be surgically sterile or if sexually active must use an acceptable
             method of contraception during the study.

          -  Considered suitable to receive either regimen in the clinical judgement of the
             treating investigator.

        Exclusion Criteria:

          -  Patients with only non-measurable lesions in the liver according to RECIST criteria

          -  Incomplete recovery from previous liver surgery, e.g. unresolved biliary tree
             obstruction or biliary sepsis or inadequate liver function

          -  Biliary stent in situ

          -  Main trunk Portal Vein Thrombosis (PVT)

          -  Ascites, even if controlled with diuretics. (A minor peri-hepatic rim of ascites
             detected at imaging is acceptable).

          -  Mixed hepatocellular carcinoma - intrahepatic cholangiocarcinoma (HCC-ICC) disease

          -  History of prior malignancy. Exceptions include in-situ carcinoma of the cervix
             treated by cone-biopsy/resection, non-metastatic basal and/or squamous cell
             carcinomas of the skin, recurrent intra-hepatic cholangiocarcinoma post local
             treatment or any early stage (stage 1) malignancy adequately resected with curative
             intent at least 5 years prior to study entry

          -  Suspicion of any bone metastasis/metastases or central nervous system
             metastasis/metastases on clinical or imaging examination.

          -  Prior internal or external radiation delivered to the liver.

          -  Pregnancy; breast feeding.

          -  Participation within 28 days prior to randomization, in an active part of another
             clinical study that would compromise any of the endpoints of the study.

          -  Evidence of ongoing active infection that may affect treatment feasibility or
             outcome.

          -  Prior Whipple's procedure.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jordi Bruix, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Head of the Hepatic Oncology Unit, Hospital Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Harpreet Wasan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial College Healthcare Hammersmith Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Florence Chow</last_name>
    <phone>49 228 1840 713</phone>
    <email>fchow@sirtex-europe.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Canberra Hospital</name>
      <address>
        <city>Garran</city>
        <state>Australian Capital Territory</state>
        <zip>2605</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Prof. Desmond Yip</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Macquarie University Hospital</name>
      <address>
        <city>North Ryde</city>
        <state>New South Wales</state>
        <zip>2109</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Pirooz Poursoltan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Box Hill Hospital</name>
      <address>
        <city>Box Hill</city>
        <state>Victoria</state>
        <zip>3128</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Prasad Cooray</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Peter MacCallum Cancer Centre</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3000</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Prof. Lara Lipton</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sir Charles Gairdner Hospital</name>
      <address>
        <city>Nedlands</city>
        <state>Western Australia</state>
        <zip>6009</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Kevin Jasas</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cliniques Universitaires Saint-Luc</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Prof. Ivan Borbath</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prof. Pierre Goffette</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Renaud Lhommel</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Marc van den Eynde</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Prof. Eric van Cutsem</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Raymond Aerts</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prof. Chris Verslype</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Wim Laleman</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prof. Christophe Deroose</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prof. Geert Maleux</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Saint Andre - CHU Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <zip>3300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Prof. Jean-Frederic Blanc</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Bruno Lapuyade</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Jean-Baptiste Pinaquy</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Dr. Thomas Decaens</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Christian Sengel</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Mircea Chirica</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Christian Letoublon</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Jean-Philippe Vuillez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Paoli Calmettes</name>
      <address>
        <city>Marseille</city>
        <zip>13009</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Prof. Jean-Luc Raoul</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Marine Gilabert</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Gilles Piana</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Sandrine Oziel-Taieb</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Anthony Sarran</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Isabelle Brenot-Rossi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Olivier Turrini</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Prof. Eric Assenat</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Marie Dupuy</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prof. Boris Guiu</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Mazard Thibault</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prof. Jean Michel Fabre</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Diana Ilonca</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Christophe Carenco</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Eugene Marquis Hospital de Jour</name>
      <address>
        <city>Rennes</city>
        <zip>35042</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Dr. Julien Edeline</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Samuel LeSourd</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Marc Pracht</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Astrid Lieve</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Berengere Leconte</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Etienne Garin</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Karim Boudjema</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Yan Rolland</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Gustave Roussy</name>
      <address>
        <city>Villejuif</city>
        <zip>94805</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dr. David Malka</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Jean Lumbroso</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prof. Thierry de Baeare</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Valerie Boige</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prof. Dominique Elias</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Diane Goere</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prof. Michel Ducreux</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Charite - Universitatsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Dr. med Marianne Sinn</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prof. Dr. med. Bernhard Gebauer</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prof. Dr. med Holger Amthauer</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Imke Schatka</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Uwe Pelzer</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Anja Juhling</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Jana Striefler</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Florian Wedel</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>PD Dr. Christian Furth</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Bonn</name>
      <address>
        <city>Bonn</city>
        <zip>53127</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Prof. Christian Strassburg</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Steffen Manekeller</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Carsten Meyer</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Guido Kukuk</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prof. Markus Essler</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Maria Gonzalez-Carmona</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Jena</name>
      <address>
        <city>Jena</city>
        <zip>07743</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Dr. Martin Freesmeyer</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Thomas Winkens</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mr. Philipp Seifert</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Rene Aschenbach</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Udo Lindig</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Denise Mathes</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Astrid Bauschke</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Christina Malessa</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prof. Ulf Teichgraeber</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Florian Burkenmeyer</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Koeln</name>
      <address>
        <city>Koeln</city>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Dr. Dirk Waldschmidt</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Bianca Jacobs</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Bianca Holzapfel</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Fabian Kuetting</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prof. Matthias Schmidt</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. de Hua Chang</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Alexander Bunck</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Claudia Selbach</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Leipzig AoR</name>
      <address>
        <city>Leipzig</city>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Prof. Dr. Thomas Berg</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>PD Dr. Johannes Wiegand</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Otto-von-Guericke-Universitat Magdeburg</name>
      <address>
        <city>Magdeburg</city>
        <zip>39120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Prof. Dr. med. Maciej Pech</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prof. Max Seidensticker</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Ricarda Seidensticker</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Konrad Mohnike</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ms. Susanne Penzlin</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Tina Bretschneider</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Erika Kettner</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Christian Schulz</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Marino Venerito</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Benjamin Garlipp</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Thekla Wallbaum</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum der Johannes Gutenberg Universitat Mainz</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Prof. Peter Galle</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prof. Jens Marquardt</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prof. Michael Pitton</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Matthias Miederer</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum der Universitaet Meunchen</name>
      <address>
        <city>Muenchen</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Prof. Volker Heinemann</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prof. Stefan Boeck</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Sebastian Lehner</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Philipp Paprottka</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Clemens Cyran</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Melvin D'Anastasi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prof. Dr. med Jens Ricke</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinik Tuebingen</name>
      <address>
        <city>Tuebingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Prof. Lars Zender</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Roland Syha</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ms. Vera Belka</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinico Sant' Orsola-Malpighi</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Prof. Rita Golfieri</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Cristina Mosconi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Alberta Cappelli</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Simona Civollani</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Fabio Monari</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Matteo Renzulli</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prof. Giovanni Brandi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Ingrid Garajova</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prof. Franco Trevisani</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Antonio Daniele Pinna</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prof. Giorgio Ercolani</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Stefano Fanti</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>U.O. Oncologia Medica 2 Universitaria</name>
      <address>
        <city>Pisa</city>
        <zip>56126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Dr. Gianluca Masi</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Irene Bargellini</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Lorenzo Fornaro</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Guiseppe Boni</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Caterina Vivaldi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Humanitas Research Hospital</name>
      <address>
        <city>Rozzano</city>
        <zip>20089</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Prof. Arturo Chiti</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prof. Guido Torzilli</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Lorenza Rimassa</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Vittorio Pedicini</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Marcello Rodari</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Giulia Manfrinato</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Katia Marzo</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Ilaria Vaccaro</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Roberto Ceriani</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AMC Academic Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <zip>1105</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dr. Heinz-Josef Klumpen</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. J. Wilmink</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Adriaan Dirk Bins</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prof. T.M. van Gulik</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Roel Bennink</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prof. Otto van Delden</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dr. Jordi Bruix</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Marta Burrel</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Marta Barrufet</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Joan Maurel</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Josep Fuster</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Francisco Lomena</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Maria Elisa Reig</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Alejandro Forner</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Andrea Ribeiro</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Alvaro Diaz Gonzalez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinica Universitaria de Navarra</name>
      <address>
        <city>Pamplona</city>
        <zip>31008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Prof. Bruno Sangro</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hammersmith Hospital Imperial College Healthcare NHS Trust</name>
      <address>
        <city>London</city>
        <zip>W12 0HS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Dr. Harpreet Wasan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Christie NHS Foundation Trust</name>
      <address>
        <city>Manchester</city>
        <zip>M20 4BX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Prof. Juan W. Valle</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Jeremy Lawrence</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Jon Bell</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Prakash Manorahan</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Thomas Westwood</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Jill Tipping</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southampton General Hospital</name>
      <address>
        <city>Southampton</city>
        <zip>S016 6YD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Dr. Brian Stedeman</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Eleonora Manca</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Francisco Sundram</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Andrew Bateman</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Clatterbridge Cancer Centre NHS Foundation Trust</name>
      <address>
        <city>Wirral</city>
        <zip>CH63 4JY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Prof. Daniel Palmer</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Olusola O. Faluyi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Graeme Poston</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Hassan Malik</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Jonathan Evans</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prof. Sobhan Vinjamuri</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Mark Baker</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Nick Stern</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Melvyn Carroll</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mr. Pembe Yesildag</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Belgium</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Spain</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <lastchanged_date>April 4, 2017</lastchanged_date>
  <firstreceived_date>May 13, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cholangiocarcinoma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Gemcitabine</mesh_term>
    <mesh_term>Cisplatin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
